Cassava Sciences | PTIE - O Lucro Antes De Impostos





O Lucro Antes De Impostos Alterar Data
Abbott USD 2.36B 178M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cassava Sciences USD -10.81M 33.41M 2025-09
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Geron USD -31.14M 12.72M 2025-12
J&J USD 4.97B 2.53B 2025-12
Merck USD 6.74B 22M 2025-09
Novartis USD 4.64B 445M 2025-12
Novavax USD 17.9M 220.94M 2025-12
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06